πŸ‡ΊπŸ‡Έ FDA
Patent

US 11825819

Crnn loss of function rodent model

granted A61KA61K49/0008

Quick answer

US patent 11825819 (Crnn loss of function rodent model) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K49/0008